WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here

Search

Track Your Article

Abstract

A COMPARATIVE STUDY ON EFFICACY OF LEVETIRACETAM WITH OTHER ANTIEPILEPTIC DRUGS BY ASSESSING BEHAVIOURAL AND COGNITIVE CHANGES USING DSM-V AND MMSE SCALES

K. Sravanthi*, B.V.L. Sai Spoorthy, S. K. Nagul Shareef, S. Bhavya Sai, J. N. Suresh Kumar

ABSTRACT

Background: Epilepsy is the second common, frequently encountered neurological condition that imposes heavy burden on individual, families, and on healthcare systems. In addition to seizure-control, many of the treatment failures are due to cognition-behavioural changes which were reported as an adverse effect. Aim: To compare the efficacy of Levetiracetam with other antiepileptic drugs by assessing behavioural and cognitive changes using various scales. Method: This is a Prospective Case-Control study conducted in Guntur City Hospitals. A total of 400 sample were included, out of which 200 epileptic patients who were on antiepileptic’s and 200 are Healthy-controls. Both cognitive & behavioural changes were compared among Healthy-controls and Epileptic patients using Mini-mental scale examination and Diagnostic statistical manual of mental disorders scales, and also compared safety and efficacy of Levetiracetam with other antiepileptics. Results: In our study, knowledge about Medications and Life style modifications was provided using Counselling Aids. Among 200 Epileptic patients, 100 subjects were on Levetiracetam. Out of which cognitive changes (14%), behavioural changes(24%), both cognitive-behavioural changes(8%), whereas no changes in 54% patients. Remaining 100 Subjects were on other AED’S. Among them cognitive changes (9%), behavioural changes (14%) and both changes (3%) were observed; no changes observed in 74% patients. Conclusion: The Patients with epilepsy become seizure-free with the first prescribed AED in daily-clinical practice. In addition to seizure-control, the overall effectiveness is also determined by adverse-events, which are responsible for approximately 1/3rd of treatment failures. The study concludes that Cognitive-behavioural sideeffects occur more frequently in patients prescribed with Levetiracetam than other antiepileptics.

Keywords: Epilepsy, Cognition, Behaviour, Levetiracetam.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More